HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX ® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology (“Pulse”), today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results